Ultrashort-pulse lasers kill bacterial superbugs, spores
Researchers at Washington University School of Medicine have found that multidrug-resistant bacteria and bacterial spores can be killed by ultrashort-pulse lasers. The findings could lead to new ways to sterilize wounds and blood products without damaging human cells.
Rentschler wins NIH grant
Stacey Lynn Rentschler at the School of Medicine received a four-year $2 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH).
Nowak wins grants from NASA, Smithsonian observatory
Michael Nowak, research professor of physics in Arts & Sciences, was awarded grants totaling $75,000 from NASA for various projects. He also received funding from the Smithsonian Astrophysical Observatory.
Kim to research skin inflammation
Brian Kim, MD, at the School of Medicine, received a five-year, $2.4 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) to research skin inflammation.
Graduate students receive NSF grants
Two graduate students working with David Strait, professor of biological anthropology in Arts & Sciences, won doctoral dissertation research grants from the National Science Foundation.
Krawczynski wins grant from Smithsonian Astrophysical Observatory
Henric Krawczynski in Arts & Sciences received a $41,255 award from the Smithsonian Astrophysical Observatory for quasar research.
Bhayani named director of urologic surgery
Urologic oncologist Sam Bhayani, MD, has been named to lead the Division of Urologic Surgery in the Department of Surgery at Washington University School of Medicine.
Washington University joins major NIH effort to advance health data science in Africa
Researchers at Washington University are receiving one of 19 grant awards that will support data science research and training activities in Africa. The researchers will focus on developing new training programs in health data science in Rwanda.
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine.
Ryan receives fellowship from NIH
Jeremy Ryan, a graduate student working with Meredith Jackrel in the Department of Chemistry in Arts & Sciences, won a three-year $123,090 fellowship from the National Institutes of Health (NIH).
View More Stories